Recommendations and Guidelines:
ACIP Live Meeting Archive - October 2011
ACIP pages:
October 25-26, 2011
On this page:
- Welcome
- Human Papillomavirus Vaccine (HPV)
- Child/Adolescent Immunization Schedule
- Adult Immunization Schedule
- Hepatitis B Vaccine
- Meningococcal Vaccine (MCV)
- Public Engagement
- Agency Updates
- 13-valent Pneumococcal Conjugate Vaccine (PCV13)
- General Recommendations/Febrile Seizures
- Pertussis
- Immunization Coverage of Children/Adolescents
- Vaccine Supply
- Measles
- Influenza
Meeting Agenda October 25-26, 2011
[PDF - 83KB] (compliant)
October 25, 2011 (Day 1)
Opening Remarks
- Welcome
Dr. L Pickering
Human Papillomavirus Vaccine (HPV)
- Introduction
Dr. J Bocchini - Safety of Quadrivalent Human Papillomavirus (HPV4) Vaccine
Ms. J Gee - Post-licensure Safety Study of Quadrivalent Human Papillomavirus Vaccine among 189,629 Females
Dr. C Velicer - HPV Vaccine for Males Background and Review of Data
Dr. L Markowitz - HPV Vaccine Considerations for Males
Dr. E Dunne - VFC Resolution Update: HPV Vaccines
Dr. J Santoli
Child/Adolescent Immunization Schedule
- 2012 Immunization Schedules for Children 0 Through 18 Years of Age
Dr. C Meissner
Dr. I Beysolow
Adult Immunization Schedule
- Adult Immunization Schedule, 2012
Dr. C Bridges
Hepatitis B Vaccine
- Introduction
Dr. M Sawyer - Odds of Acute Hepatitis B Among Persons with Diabetes at Eight Emerging Infection Program Sites
Dr. S Schillie - Hepatitis B Vaccination for Adults with Diabetes: Summary of Considerations
Dr. T Murphy - Assisted Blood Glucose Monitoring
Dr. P Allweiss - Implementation of Hepatitis B Vaccination for Adults with Diabetes
Dr. K Byrd - GRADE: Hepatitis B Vaccination among Adults with Diabetes
Dr. S Schillie - Hepatitis B Vaccination for Adults with Diabetes
Dr. T Murphy
Meningococcal Vaccines
- Epidemiology of Meningococcal Disease In Infants and Young Children
J MacNeil - Cost-Effectiveness of Meningococcal Vaccination in Infants and Toddlers in the United States
Dr. I Ortega-Sanchez - Considerations for Use of Meningococcal Conjugate Vaccines in Infants and Toddlers
Dr. A Cohn - Stakeholder and Public Engagement: Meningococcal Vaccines and Infants; Public Comment
Dr. G Nowak
October 26, 2011 (Day 2)
Opening Remarks
13-valent Pneumococcal Conjugate Vaccine (PCV13)
- Introduction
Dr. M Marcy - Immunogenicity of PCV13 in adults
Dr. Peter Paradiso - Prevention of Pneumococcal Disease Among Immunocompromised Adults
Dr. K Dooling
General Recommendations/Febrile Seizures
- General Recommendations Work Group
Dr. J Duchin - Update on febrile seizures and vaccines
Dr. A Kroger
Pertussis
- Pertussis Vaccines Working Group Update
Dr. M Sawyer
Immunization Coverage
- Child and Adolescent Vaccination Coverage Levels: 2010 NIS
Dr. L Rodewald
Vaccine Supply
- Vaccine Supply Update
Dr. J Santoli
Measles
- Introduction
Dr. J Temte - Epidemiology of Measles in the United States
Dr. H McLean
Measles outbreak in Canada - Dr. G de Serres
Measles prevention activities in Mexico - Dr. V Richardson
Measles vaccination among children with HIV - Dr. G Siberry
Influenza
- Influenza; Public Comment
Introduction - Dr. W Keitel
Influenza activity update - Dr. L Grohskopf
Vaccine effectiveness - Dr. P Moro
Fluzone high-dose safety update - Dr. M Thompson
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
This page last modified on January 10, 2012
Content last reviewed on December 7, 2011
Content Source: National Center for Immunization and Respiratory Diseases
